Search Results - "KALNICKI, Shalom"

Radiation Therapy Noncompliance and Clinical Outcomes in an Urban Academic Cancer Center by Ohri, Nitin, MD, Rapkin, Bruce D., PhD, Guha, Chandan, MD, PhD, Kalnicki, Shalom, MD, Garg, Madhur, MD

“…Purpose To examine associations between radiation therapy (RT) noncompliance and clinical outcomes. Methods and Materials We reviewed all patients who…”
Get full text

Adaptive Planning in Intensity-Modulated Radiation Therapy for Head and Neck Cancers: Single-Institution Experience and Clinical Implications by Ahn, Peter H., M.D, Chen, Chin-Cheng, Ph.D, Ahn, Andrew I., M.Eng, Hong, Linda, Ph.D, Scripes, Paola G., M.S, Shen, Jin, B.S, Lee, Chen-Chiao, M.S, Miller, Ekeni, A.S, Kalnicki, Shalom, M.D, Garg, Madhur K., M.D

“…Purpose Anatomic changes and positional variability during intensity-modulated radiation therapy (IMRT) for head and neck cancer can lead to clinically…”
Get full text

Referral practices to dermatologists for the treatment of radiation dermatitis in the USA: a call for a multidisciplinary approach by Nazarian, Roya S., Lucey, Patricia, Franco, Loren, Zouzias, Christos, Chennupati, Sravana, Kalnicki, Shalom, McLellan, Beth N.

“…Purpose Acute radiation dermatitis (RD) is a disfiguring and painful rash that occurs in up to 95% of patients receiving radiation therapy (RT) for cancer…”
Get full text

Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review by Baliga, Sujith, Kabarriti, Rafi, Ohri, Nitin, Haynes–Lewis, Hilda, Yaparpalvi, Ravindra, Kalnicki, Shalom, Garg, Madhur K, Eisele, David W.

“…ABSTRACT The management of patients with recurrent head and neck cancers remains a challenging clinical dilemma. Concerns over toxicity with re‐irradiation…”
Get full text

Continuous Activity Monitoring during Concurrent Chemoradiotherapy by Ohri, Nitin, M.D, Kabarriti, Rafi, M.D, Bodner, William R., M.D, Mehta, Keyur J., M.D, Shankar, Viswanathan, Dr.P.H, Halmos, Balazs, M.D, Haigentz, Missak, M.D, Rapkin, Bruce, Ph.D, Guha, Chandan, M.B.B.S., Ph.D, Kalnicki, Shalom, M.D, Garg, Madhur, M.D

“…Abstract Background Wearable activity monitors are widely available and marketed as fitness trackers. We performed a prospective trial testing the feasibility…”
Get full text

Predictors of Radiation Therapy Noncompliance in an Urban Academic Cancer Center by Ohri, Nitin, MD, Rapkin, Bruce D., PhD, Guha, Debayan, Haynes-Lewis, Hilda, NP, Guha, Chandan, MD, PhD, Kalnicki, Shalom, MD, Garg, Madhur, MD

“…Purpose To quantify the frequency of patient noncompliance in an urban radiation oncology department and identify predictors of noncompliance. Methods and…”
Get full text

Breast cancer survivorship care during the COVID-19 pandemic within an urban New York Hospital System by Mo, Allen, Chung, Julie, Eichler, Jeremy, Yukelis, Sarah, Feldman, Sheldon, Fox, Jana, Garg, Madhur, Kalnicki, Shalom, Ohri, Nitin, Sparano, Joseph A., Klein, Jonathan

“…To examine clinicodemographic determinants associated with breast cancer survivorship follow-up during COVID-19. We performed a retrospective, population-based…”
Get full text

Who Benefits From Adjuvant Radiation Therapy for Gastric Cancer? A Meta-Analysis by Ohri, Nitin, MD, Garg, Madhur K., MD, Aparo, Santiago, MD, Kaubisch, Andreas, MD, Tome, Wolfgang, PhD, Kennedy, Timothy J., MD, Kalnicki, Shalom, MD, Guha, Chandan, MD, PhD

“…Purpose Large randomized trials have demonstrated significant survival benefits with the use of adjuvant chemotherapy or chemoradiation therapy for gastric…”
Get full text

Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer by Brodin, N Patrik, Kabarriti, Rafi, Schechter, Clyde B, Pankuch, Mark, Gondi, Vinai, Kalnicki, Shalom, Garg, Madhur K, Tomé, Wolfgang A

“…Proton therapy is a promising advancement in radiation oncology especially in terms of reducing normal tissue toxicity, although it is currently expensive and…”
Get full text

Evaluating which plan quality metrics are appropriate for use in lung SBRT by Yaparpalvi, Ravindra, Garg, Madhur K, Shen, Jin, Bodner, William R, Mynampati, Dinesh K, Gafar, Aleiya, Kuo, Hsiang-Chi, Basavatia, Amar K, Ohri, Nitin, Hong, Linda X, Kalnicki, Shalom, Tome, Wolfgang A

“…Several dose metrics in the categories-homogeneity, coverage, conformity and gradient have been proposed in literature for evaluating treatment plan quality…”
Get full text

Stereotactic body radiation therapy for stage I non-small cell lung cancer: The importance of treatment planning algorithm and evaluation of a tumor control probability model by Ohri, Nitin, Tomé, Wolfgang, Kalnicki, Shalom, Garg, Madhur

“…Stereotactic body radiation therapy (SBRT) is increasingly used to treat early-stage non-small cell lung cancer (NSCLC). A previous report introduced the term…”
Get full text

Hypofractionated Whole-Breast Radiation Therapy: Does Breast Size Matter? by Hannan, Raquibul, MD, PhD, Thompson, Reid F., MD, PhD, Chen, Yu, MD, PhD, Bernstein, Karen, MD, Kabarriti, Rafi, MD, Skinner, William, MD, Chen, Chin C., PhD, Landau, Evan, MD, Miller, Ekeni, BA, Spierer, Marnee, MD, Hong, Linda, PhD, Kalnicki, Shalom, MD

“…Purpose To evaluate the effects of breast size on dose-volume histogram parameters and clinical toxicity in whole-breast hypofractionated radiation therapy…”
Get full text

In Regard to Bruner et al by Ohri, Nitin, MD, Kalnicki, Shalom, MD, Sparano, Joseph A., MD, Garg, Madhur, MD

Get full text

Predictors of Financial Toxicity in Patients Receiving Concurrent Radiation Therapy and Chemotherapy by Jiang, Julie M., Eichler, Jeremy, Bodner, William, Fox, Jana, Garg, Madhur, Kabarriti, Rafi, Mo, Allen, Kalnicki, Shalom, Mehta, Keyur, Rivera, Amanda, Tang, Justin, Yap, Johnny, Ohri, Nitin, Klein, Jonathan

“…Financial toxicity (FT) is a significant concern for patients with cancer. We reviewed prospectively collected data to explore associations with FT among…”
Get full text

Change in Seroma Volume During Whole-Breast Radiation Therapy by Sharma, Rajiv, M.D, Spierer, Marnee, M.D, Mutyala, Subhakar, M.D, Thawani, Nitika, M.D, Cohen, Hillel W., Dr.P.H, Hong, Linda, Ph.D, Garg, Madhur K., M.D, Kalnicki, Shalom, M.D

“…Purpose After breast-conserving surgery, a seroma often forms in the surgical cavity. If not drained, it may affect the volume of tumor bed requiring a boost…”
Get full text

Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer by Zhu, Shaoyu, Brodin, N. Patrik, English, Keara, Ohri, Nitin, Chuy, Jennifer W., Rajdev, Lakshmi N., Narang, Rahul, Kalnicki, Shalom, Guha, Chandan, Garg, Madhur K., Kabarriti, Rafi

“…There is recent interest in treating locally advanced rectal cancer (LARC) patients with total neoadjuvant therapy (TNT). However, whether TNT is associated…”
Get full text

1522 Revitalizing systemic immune responses in progressive NSCLC using FLT3L and SBRT by Mathew, Divij, Ohri, Nitin, Ngiow, Shin Foong, Wumesh, KC, Halmos, Balazs, Garg, Madhur, Levsky, Jeffrey M, Cheng, Haiying, Gucalp, Rasim, Bodner, William, Kabarriti, Rafi, Gutierrez-Chavez, Claudia, Zakharia, Adel, Kalnicki, Shalom, Yellin, Michael J, Keler, Tibor, Giles, Josephine R, Guha, Chandan, John Wherry, E

“…BackgroundFms-like tyrosine kinase 3 ligand (FLT3L) is a potent hematopoietic growth factor that mobilizes stem cells and increases the number of circulating…”
Get full text

Hybrid tandem and ovoids brachytherapy in locally advanced cervical cancer: impact of dose and tumor volume metrics on outcomes by Rivera, Amanda, Wassel, Monica, Brodin, Patrik N, Yaparpalvi, Ravindra, Velten, Christian, Kabarriti, Rafi, Garg, Madhur, Kalnicki, Shalom, Mehta, Keyur J

“…To report the impact of dose and tumor volume metrics at brachytherapy on outcomes for locally advanced cervical cancer treated with tandem and ovoids…”
Get full text

A positron emission tomography radiomic signature for distant metastases risk in oropharyngeal cancer patients treated with definitive chemoradiotherapy by Brodin, N. Patrik, Velten, Christian, Lubin, Jonathan, Eichler, Jeremy, Zhu, Shaoyu, Saha, Sneha, Guha, Chandan, Kalnicki, Shalom, Tomé, Wolfgang A., Garg, Madhur K., Kabarriti, Rafi

“…•The wavelet_LHL_GLDZM_LILDE feature was found to be associated with progression-free survival.•A binary radiomics risk score was strongly associated with…”
Get full text

The Evolving Role of Positron Emission Tomography-Computed Tomography in Organ-Preserving Treatment of Head and Neck Cancer by Garg, Madhur K., MD, Glanzman, Jonathan, MD, Kalnicki, Shalom, MD

“…The introduction of image-guided radiation therapy and intensity-modulated radiation therapy has led to unparalleled advances in achieving precise dose…”
Get full text